Mersana Therapeutics, Inc. revenue breakdown overview

Mersana Therapeutics, Inc. revenue for the last year amounted to 36.85 M USD, the most of which — 36.85 M USD — came from its highest performing source at the moment, Antibody Drug Conjugate, the year earlier bringing 26.58 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Mersana Therapeutics, Inc. 36.85 M USD, and the year before that — 26.58 M USD.